Journal article · 2009

The CATIE and CUtLASS Studies in Schizophrenia: Results and Implications for Clinicians

Dieter Naber, Martin Lambert

CNS Drugs, PAP(8), 649–659 · Published 1 June 2009 · DOI 10.2165/00023210-200923080-00002

View at the publisherCite this paper

In brief

“The CATIE and CUtLASS Studies in Schizophrenia: Results and Implications for Clinicians” is a 2009 journal article by Dieter Naber and Martin Lambert, published in CNS Drugs. OpenAlex counts 133 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
133
Most cited in
2017 (9)
Field-weighted impact
6.29
References
59
Authors
2

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Naber, D., & Lambert, M. (2009). The CATIE and CUtLASS Studies in Schizophrenia: Results and Implications for Clinicians. CNS Drugs, PAP(8), 649–659. https://doi.org/10.2165/00023210-200923080-00002

MLA 9

Naber, Dieter, and Martin Lambert. “The CATIE and CUtLASS Studies in Schizophrenia: Results and Implications for Clinicians.” CNS Drugs, vol. PAP, no. 8, 2009, pp. 649–659. https://doi.org/10.2165/00023210-200923080-00002.

Chicago

Naber, Dieter and Martin Lambert. 2009. “The CATIE and CUtLASS Studies in Schizophrenia: Results and Implications for Clinicians.” CNS Drugs PAP (8): 649–659. https://doi.org/10.2165/00023210-200923080-00002.

Harvard

Naber, D. and Lambert, M. (2009) ‘The CATIE and CUtLASS Studies in Schizophrenia: Results and Implications for Clinicians’, CNS Drugs, PAP(8), pp. 649–659. doi:10.2165/00023210-200923080-00002.

IEEE

D. Naber and M. Lambert, “The CATIE and CUtLASS Studies in Schizophrenia: Results and Implications for Clinicians,” CNS Drugs, vol. PAP, no. 8, pp. 649–659, 2009, doi: 10.2165/00023210-200923080-00002.

BibTeX

@article{naber2009catie,
  title     = {{The CATIE and CUtLASS Studies in Schizophrenia: Results and Implications for Clinicians}},
  author    = {Naber, Dieter and Lambert, Martin},
  journal   = {CNS Drugs},
  year      = {2009},
  volume    = {PAP},
  number    = {8},
  pages     = {649--659},
  doi       = {10.2165/00023210-200923080-00002},
  url       = {https://doi.org/10.2165/00023210-200923080-00002}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201799
201888
201988
202099
202133
202255
202333
202433
202511
202611

Its field-weighted citation impact is 6.29: it has been cited 6.29 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • schizophrenia
  • atypical antipsychotics
  • typical antipsychotics
  • CATIE trial
  • olanzapine
  • quetiapine
  • risperidone
  • ziprasidone

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Naber, D., & Lambert, M. (2009). The CATIE and CUtLASS Studies in Schizophrenia: Results and Implications for Clinicians. CNS Drugs, PAP(8), 649–659. https://doi.org/10.2165/00023210-200923080-00002

How many times has this paper been cited?

133 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Dieter Naber, Martin Lambert.

What is the DOI of this paper?

10.2165/00023210-200923080-00002, permanently at https://doi.org/10.2165/00023210-200923080-00002. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.